DE602005016534D1 - Medikament zur prävention oder behandlung von häufigem harndrang oder harninkontinenz - Google Patents

Medikament zur prävention oder behandlung von häufigem harndrang oder harninkontinenz

Info

Publication number
DE602005016534D1
DE602005016534D1 DE602005016534T DE602005016534T DE602005016534D1 DE 602005016534 D1 DE602005016534 D1 DE 602005016534D1 DE 602005016534 T DE602005016534 T DE 602005016534T DE 602005016534 T DE602005016534 T DE 602005016534T DE 602005016534 D1 DE602005016534 D1 DE 602005016534D1
Authority
DE
Germany
Prior art keywords
prevention
treatment
harnin
harndrang
continence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016534T
Other languages
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of DE602005016534D1 publication Critical patent/DE602005016534D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005016534T 2004-03-24 2005-03-17 Medikament zur prävention oder behandlung von häufigem harndrang oder harninkontinenz Active DE602005016534D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2004/004000 WO2005092321A1 (ja) 2004-03-24 2004-03-24 頻尿または尿失禁の予防または治療用医薬組成物
PCT/JP2005/004825 WO2005089742A1 (ja) 2004-03-24 2005-03-17 頻尿または尿失禁の予防または治療用医薬

Publications (1)

Publication Number Publication Date
DE602005016534D1 true DE602005016534D1 (de) 2009-10-22

Family

ID=34993428

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016534T Active DE602005016534D1 (de) 2004-03-24 2005-03-17 Medikament zur prävention oder behandlung von häufigem harndrang oder harninkontinenz

Country Status (12)

Country Link
US (1) US20080242674A1 (de)
EP (1) EP1728508B1 (de)
AT (1) ATE442137T1 (de)
CA (1) CA2559646A1 (de)
CY (1) CY1109546T1 (de)
DE (1) DE602005016534D1 (de)
DK (1) DK1728508T3 (de)
ES (1) ES2331369T3 (de)
PL (1) PL1728508T3 (de)
PT (1) PT1728508E (de)
SI (1) SI1728508T1 (de)
WO (2) WO2005092321A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
FR2895259B1 (fr) * 2005-12-22 2008-02-22 Urosphere Sas Methodes de traitement des incontinences urinaires
WO2008106125A2 (en) 2007-02-26 2008-09-04 Concert Pharmaceuticals, Inc. Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
CN101815520A (zh) * 2007-10-02 2010-08-25 东亚制药株式会社 治疗或预防良性前列腺增生和下尿路症状的组合物和方法
EP2363397A4 (de) * 2008-11-07 2012-07-11 Dainippon Sumitomo Pharma Co Neues nützliches therapeutikum für niedrigeres urinausscheidende fläche symptom
JP5426801B2 (ja) * 2011-08-25 2014-02-26 キッセイ薬品工業株式会社 低活動膀胱の予防または治療用医薬組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6426517A (en) * 1987-07-21 1989-01-27 Sankyo Co Remedy for dysuria
SE504276C2 (sv) * 1993-12-30 1996-12-23 Siko Medical Ab Ventil avsedd att placeras i urinröret
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6410554B1 (en) * 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP3154710B1 (ja) * 1999-08-09 2001-04-09 山之内製薬株式会社 下部尿路症治療剤
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
CA2440141A1 (en) * 2001-03-06 2002-09-12 Cellegy Pharmaceuticals, Inc. Compounds and methods for the treatment of urogenital disorders
JP4132020B2 (ja) * 2001-03-12 2008-08-13 キッセイ薬品工業株式会社 フェノキシ酢酸誘導体の製造中間体およびその使用方法
JP2003055261A (ja) * 2001-08-08 2003-02-26 Pfizer Prod Inc 製剤組合せ
BR0212494A (pt) * 2001-09-13 2004-08-24 Kissei Pharmaceutical Cristais de derivados de hidróxinorefedrina
KR20060124603A (ko) * 2003-11-03 2006-12-05 베링거 인겔하임 인터내셔날 게엠베하 베타-3-아드레날린 수용체 효능제 및 알파 길항제 및/또는5-알파-리덕타제 억제제를 함유하는 약제학적 조성물
CN1930123B (zh) * 2004-03-05 2010-06-23 橘生药品工业株式会社 用于预防或治疗伴有神经障碍的膀胱过度活动症的医药组合物

Also Published As

Publication number Publication date
SI1728508T1 (sl) 2010-01-29
WO2005089742A8 (ja) 2005-11-03
PT1728508E (pt) 2009-10-20
US20080242674A1 (en) 2008-10-02
ATE442137T1 (de) 2009-09-15
PL1728508T3 (pl) 2010-02-26
WO2005092321A1 (ja) 2005-10-06
WO2005089742A1 (ja) 2005-09-29
EP1728508B1 (de) 2009-09-09
CA2559646A1 (en) 2005-09-29
CY1109546T1 (el) 2014-08-13
EP1728508A4 (de) 2008-02-13
EP1728508A1 (de) 2006-12-06
DK1728508T3 (da) 2010-01-25
ES2331369T3 (es) 2009-12-30

Similar Documents

Publication Publication Date Title
SG159388A1 (en) Antibacterial agents
CY1109546T1 (el) Φαρμακο για την προληψη η θεραπεια της συχνουριας η της ουρικης ακρατειας
WO2007127635A3 (en) Diketo-piperazine and piperidine derivatives as antiviral agents
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
EP2639229A3 (de) Thiazolderivate und deren Verwendung als VAP-1-Hemmer
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
RU2002124873A (ru) Глюкопиранозилоксибензилбензольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для получения указанных производных
WO2009063202A3 (en) Use of crth2 antagonist compounds
WO2006036928A3 (en) Inhibitors of matrix metalloproteinases to treat neurological disorders
BR0315580A (pt) Derivados de metileno uréia
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
SE0202429D0 (sv) Novel Compounds
SE0301232D0 (sv) Novel use
ATE357453T1 (de) Comt-inhibitoren
ATE451922T1 (de) Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren
SE9903894D0 (sv) Novel compounds
EA200800071A1 (ru) Производные бензофуранила как ингибиторы 5-нт6-рецептора
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
DE602005017581D1 (de) Verwendung von substituierten 1,2,3-indolizin-derivaten zur behandlung von krankheiten im zusammenhang mit einer pathologischen angiogenese
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
WO2008058995A3 (de) Verwendung von cytohesin-inhibitoren zur chemischen induktion von langlebigkeit
NO20074661L (no) Anvendelse av en forbindelse
WO2006030322A3 (en) Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions
NO20082656L (no) N-sulfamoyl-N'-benzopyranpiperidiner som inhibitorer av karbonsyreanhydraser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition